BRIANNA DILLON: Open Payments
NPI 1063870749 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 32 payments from 11 companies in 2025. Trend: 2023 $928 · 2024 $1,010 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $155 |
| Neurocrine BioSciences, Inc. | 1 | $109 |
| Otsuka America Pharmaceutical, Inc. | 1 | $103 |
| Lilly USA, LLC | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| ABBVIE INC. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| PFIZER INC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: INGREZZA, REXULTI, Ozempic, ZEPBOUND, VRAYLAR, CAPLYTA, Wegovy, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
